Nav: Home

Zebrafish capture a 'window' on the cancer process

June 04, 2019

Cancer-related inflammation impacts significantly on cancer development and progression. New research has observed in zebrafish, for the first time, that inflammatory cells use weak spots or micro-perforations in the extracellular matrix barrier layer to access skin cancer cells.

The research, led by the University of Bristol and published in Cell Reports today [Tuesday 4 June], used translucent zebrafish to model several sorts of skin cancer and live image how inflammatory cells find the growing cancer cells in the skin. To access the cancer cells, the immune cells need to first breach an extracellular matrix barrier layer called the basement membrane zone.

The researchers observed weak spots in the basement membrane zone, which the inflammatory cells use as easy routes to access the cancer. Those clones of cancer cells nearest to the weak spots tend to receive more inflammatory cell visits and as a consequence they grow faster.

Paul Martin, Professor of Cell Biology in the Schools of Biochemistry and Physiology, Pharmacology & Neuroscience at the University of Bristol, said: "As the zebrafish are translucent, we can watch inflammatory cells interacting with cancer cells in ways not possible in our own tissues.

"This 'window' on the cancer process has revealed 'weak spots' in the barrier layer that inflammatory cells must breach in order to access and feed the cancer cells within the skin. Now we know these micro-perforations exist we can target them with cancer therapeutics."

Inflammatory cells (white blood cells) are known to be key players encouraging cancer malignancy from the earliest stages of cancer initiation, but it has been unclear how they gain access to the cancer cells which generally develop within epithelial tissues, which have a barrier layer of extracellular matrix between them and the tissues from where the inflammatory cells arise. Inflammatory cells could kill the growing cancer but instead tend to nourish it and encourage cancer progression.

The study's findings have clear clinical relevance to cancer patients because microperforations in the basement membrane zone have been shown to occur in human airways and guts and so could act as similar portals to let inflammatory cells gain access to the cancer.
-end-
The research has been funded by CRUK and Wellcome Trust.

Paper

'Proteolytic and opportunistic breaching of the basement membrane zone by immune cells during tumour initiation' by Paul Martin et al in Cell Reports

University of Bristol

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...